Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition

Cotogni, Paolo; Monge, Taira; Fadda, M.; Francesco, Antonella De

doi:10.1186/s12885-018-4904-6

Cited by 43 publications

(31 citation statements)

References 52 publications

(62 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two recent prospective studies have investigated the effects of PN in cancer patients receiving chemoradiotherapy using also BIVA [78,79]. Early 7-day supplemental PN resulted in significantly improved phase angle, handgrip strength, and serum prealbumin levels in 118 hypophagic and hospitalized cancer patients at nutritional risk [78].…”

Section: Parenteral Nutritionmentioning

confidence: 99%

“…After 90 days of HPN, malnourished cancer outpatients experienced significantly improved nutritional status (Patient-Generated Subjective Global Assessment and BMI), performance status (KPS), prognostic score (modified Glasgow prognostic score), and some BIVA measures [79]. Moreover, reactance, resistance, and phase angle were significantly associated with survival at T0, T1, and T2, respectively [79].…”

Section: Parenteral Nutritionmentioning

confidence: 99%

See 1 more Smart Citation

Nutritional Therapy in Cancer Patients Receiving Chemoradiotherapy: Should We Need Stronger Recommendations to Act for Improving Outcomes?

Cotogni¹,

Pedrazzoli²,

Waele³

et al. 2019

J. Cancer

Self Cite

View full text Add to dashboard Cite

One of the challenges during chemotherapy and radiotherapy is to complete the planned cycles and doses without dose-limiting toxicity. Growing evidence clearly demonstrates the relationship between dose-limiting toxicity and low muscle mass. Moreover, malnutrition leads to low performance status, impaired quality of life, unplanned hospital admissions, and reduced survival. In the past, the lack of clear and authoritative recommendations and guidelines has meant that oncologists have not always fully appreciated the importance of nutritional therapy in patients receiving anticancer treatments. Therefore, collaboration between oncologists and clinical nutrition specialists needs to be urgently improved. Recent guidelines from scientific societies and practical recommendations by inter-society consensus documents can be summarized as follows: 1) timely nutritional therapy should be carefully considered if patients undergoing anticancer treatments are malnourished or at risk of malnutrition due to inadequate oral intake; 2) if oral intake is inadequate despite counseling and oral nutritional supplements, supplemental enteral nutrition or, if this is not sufficient or feasible, parenteral nutrition should be considered; 3) home artificial nutrition should be prescribed and regularly monitored using defined protocols developed between oncologists and clinical nutrition specialists; 4) appropriate nutritional management in the context of simultaneous care should become a guaranteed right for all patients with cancer. The purpose of this review is to provide oncologists with an overview of the aims and current evidence about nutrition in oncology, together with updated practical and concise recommendations on the application of nutritional therapy in cancer patients receiving chemoradiotherapy.

show abstract

Section: Parenteral Nutritionmentioning

confidence: 99%

Section: Parenteral Nutritionmentioning

confidence: 99%

Nutritional Therapy in Cancer Patients Receiving Chemoradiotherapy: Should We Need Stronger Recommendations to Act for Improving Outcomes?

Cotogni¹,

Pedrazzoli²,

Waele³

et al. 2019

J. Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

“…Historically, the identification of patients at risk of malnutrition relied on weight loss and body mass index (BMI) trajectory since diagnosis [7]. However, patients are often subjected to fluid imbalance [8] and/or may suffer from obesity prior to their cancer diagnosis [4]. Thus, confounding factors limit the utility of traditional anthropometric measures as a reliable marker of nutritional status (NS) [9].…”

Section: Introductionmentioning

confidence: 99%

Nutritional Status and Quality of Life in Hospitalised Cancer Patients Who Develop Intestinal Failure and Require Parenteral Nutrition: An Observational Study

et al. 2020

View full text Add to dashboard Cite

(1) Background: Malnutrition in cancer patients impacts quality of life (QoL) and performance status (PS). When oral/enteral nutrition is not possible and patients develop intestinal failure, parenteral nutrition (PN) is indicated. Our aim was to assess nutritional status, QoL, and PS in hospitalised cancer patients recently initiated on PN for intestinal failure. (2) Methods: The design was a cross-sectional observational study. The following information was captured: demographic, anthropometric, biochemical and medical information, as well as nutritional screening tool (NST), patient-generated subjective global assessment (PG-SGA), functional assessment of cancer therapy-general (FACT-G), and Karnofsky PS (KPS) data. (3) Results: Among 85 PN referrals, 30 oncology patients (56.2 years, 56.7% male) were identified. Mean weight (60.3 ± 16.6 kg) corresponded to normal body mass index values (21.0 ± 5.1 kg/m2). However, weight loss was significant in patients with gastrointestinal tumours (p < 0.01). A high malnutrition risk was present in 53.3–56.7% of patients, depending on the screening tool. Patients had impaired QoL (FACT-G: 26.6 ± 9.8) but PS indicated above average capability with independent daily activities (KPS: 60 ± 10). (4) Conclusions: Future research should assess the impact of impaired NS and QoL on clinical outcomes such as survival, with a view to encompassing nutritional and QoL assessment in the management pathway of this patient group.

show abstract

“…Adjunct BIA and weight loss monitoring are non-invasive, easy-to-use, and promising tools regarding the screening and assessment of the nutritional status of HNC patients, with prognostic value. A number of studies in other cancer patient populations highlight the prognostic role of PA and the utility of BIA [35,39,52,82,83], European Society fpr Parenteral and Enteral Nutrition (ESPEN) guidelines suggest the use of BIA in patients undergoing hematopoietic stem cell transplantation [84].…”

Section: Discussionmentioning

confidence: 99%

Can Bioelectrical Impedance Analysis and BMI Be a Prognostic Tool in Head and Neck Cancer Patients? A Review of the Evidence

Mantzorou

Tolia

Poultsidi

et al. 2020

Cancers

View full text Add to dashboard Cite

Background: Malnutrition can significantly affect disease progression and patient survival. The efficiency of weight loss and bioimpedance analysis (BIA)-derived measures in the evaluation of malnutrition, and disease progression and prognosis in patients with head and neck cancer (HNC) are an important area of research. Method: The PubMed database was thoroughly searched, using relative keywords in order to identify clinical trials that investigated the role of BIA-derived measures and weight loss on the disease progression and prognosis of patients with HNC. Twenty-seven studies met the criteria. More specifically, six studies examined the prognostic role of the tissue electrical properties in HNC patients; five examined the role of the tissue electrical properties on identifying malnutrition; four studies looked at the changes in the tissue electrical properties of HNC patients; and 12 examined the prognostic role of weight loss on survival and/or treatment outcomes. Results: Several studies have investigated the role of nutritional status tools on prognosis in HNC patients. Current studies investigating the potential of BIA-derived raw data have shown that phase angle (PA) and capacitance of the cell membrane may be considered prognostic factors of survival. Weight loss may be a prognostic factor for treatment toxicity and survival, despite some conflicting evidence. Conclusions: Further studies are recommended to clarify the role of BIA-derived measures on patients’ nutritional status and the impact of PA on clinical outcomes as well as the prognostic role of weight loss.

show abstract

Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition

Cited by 43 publications

References 52 publications

Nutritional Therapy in Cancer Patients Receiving Chemoradiotherapy: Should We Need Stronger Recommendations to Act for Improving Outcomes?

Nutritional Therapy in Cancer Patients Receiving Chemoradiotherapy: Should We Need Stronger Recommendations to Act for Improving Outcomes?

Nutritional Status and Quality of Life in Hospitalised Cancer Patients Who Develop Intestinal Failure and Require Parenteral Nutrition: An Observational Study

Can Bioelectrical Impedance Analysis and BMI Be a Prognostic Tool in Head and Neck Cancer Patients? A Review of the Evidence

Contact Info

Product

Resources

About